ReviewCureus2024

Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India.

Sanjay Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.